Sun Sep 28 00:00:00 UTC 2025: Okay, here’s a summary of the text and a rewritten version as a news article, keeping the Indian perspective in mind:

**Summary:**

The article discusses the potential of Ivermectin as a tool in the fight against malaria, particularly in regions where progress has stalled. While India has seen significant reductions in malaria cases, some areas still struggle. Ivermectin, originally used for parasitic worms, has shown promise in killing mosquitoes that bite humans treated with it, potentially reducing malaria transmission. Trials in Kenya showed a significant reduction in malaria cases, but a trial in Guinea-Bissau did not. The drug is considered safe, but resistance is a concern. The article emphasizes the need for ongoing research, monitoring resistance, and exploring combination therapies to maximize the effectiveness of Ivermectin in malaria control efforts, especially in underserved regions.

**News Article:**

**The Hindu: Wonder Drug Ivermectin Shows Promise in Malaria Fight, but Resistance Looms**

**September 28, 2025 05:30 am IST**

**NEW DELHI:** As India celebrates significant strides in reducing malaria cases over the last decade, attention is turning to innovative strategies to combat the disease in persistent transmission zones. A promising new approach involves the use of Ivermectin, a drug traditionally used for parasitic worms, as a tool to kill malaria-carrying mosquitoes, that bite humans.

While India has witnessed an over 80% decline in malaria cases, particularly in urban and semi-urban areas, challenges remain in certain districts of Odisha, Chhattisgarh, Jharkhand, and the Northeastern states.

Ivermectin is being investigated as an “endectocide” – a systemic insecticide working from inside the human body. The drug has already been safely administered to over four billion people for other parasitic infections.

Recent trials, notably the BOHEMIA trial in Kenya, have shown positive results, with a 26% reduction in malaria cases in areas where Ivermectin was administered. However, a study in Guinea-Bissau showed no significant difference and researchers claimed the timing and dosing may not have been sufficient. The results come with mixed reactions as in some cases, malaria cases slightly increased in ivermectin administered areas.

The success of Ivermectin hinges on addressing the looming threat of resistance. Overuse in veterinary medicine has already led to resistance in some ectoparasites. Vigilant monitoring and the development of alternative strategies, such as combination therapies and novel drug formulations, are crucial to ensure the long-term effectiveness of Ivermectin in malaria control.

For India, Ivermectin presents a potential supplementary tool, alongside existing interventions like bed nets and indoor spraying, particularly in remote and underserved areas where malaria transmission remains a persistent challenge. The ability to integrate Ivermectin administration into existing deworming programs further enhances its practicality and cost-effectiveness.

The Indian scientific community needs to closely monitor the ongoing research and contribute to the development of strategies to mitigate resistance. By combining innovation, vigilance, and a community-focused approach, India can continue to progress towards its goal of malaria elimination.

Read More